Výsledky vyhledávání - Michael Halank

Upřesnit hledání
  1. 1
    Everolimus in Patients with Severe Pulmonary Hypertension: A Safety and Efficacy Pilot Trial

    Everolimus in Patients with Severe Pulmonary Hypertension: A Safety and Efficacy Pilot Trial Autor Hans‐Jürgen Seyfarth, Stefan Hammerschmidt, Michael Halank, Petra Neuhaus, Hubert Wirtz

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia

    Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia Autor Martin Kolditz, Michael Halank, Bernhard Schulte-Hubbert, S. Bergmann, Steffen Albrecht, G. Höffken

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial

    Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial Autor Marius M. Hoeper, Michael Halank, Heinrike Wilkens, Andreas Günther, G Weimann, Irmingard Gebert, Hanno Leuchte, Jürgen Behr

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Bosentan therapy for portopulmonary hypertension

    Bosentan therapy for portopulmonary hypertension Autor Marius M. Hoeper, Michael Halank, Christian Marx, Gert Hoeffken, Hans-Juergen Seyfarth, J. Schauer, J Niedermeyer, J Winkler

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT‐1/‐2 studies

    Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT‐1/‐2 studies Autor Rodrigo Cartin‐Ceba, Michael Halank, Hossein Ardeschir Ghofrani, Marc Humbert, John P. Mattson, Arno Fritsch, Michael J. Krowka

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Experience with inhaled iloprost and bosentan in portopulmonary hypertension

    Experience with inhaled iloprost and bosentan in portopulmonary hypertension Autor Marius M. Hoeper, Hans-Juergen Seyfarth, Gert Hoeffken, Hubert Wirtz, Edda Spiekerkoetter, Mathias W. Pletz, Tobias Welte, Michael Halank

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study

    Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study Autor Hossein Ardeschir Ghofrani, Marius M. Hoeper, Michael Halank, F. J. Meyer, G. Staehler, Jürgen Behr, Ralf Ewert, G Weimann, Friedrich Grimminger

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Exercise Training Improves Exercise Capacity and Quality of Life in Patients with Inoperable or Residual Chronic Thromboembolic Pulmonary Hypertension

    Exercise Training Improves Exercise Capacity and Quality of Life in Patients with Inoperable or Residual Chronic Thromboembolic Pulmonary Hypertension Autor Christian Nagel, Felix Prange, Stefan Guth, Herb Jochen, Nicola Ehlken, Christine Fischer, Frank Reichenberger, Stephan Rosenkranz, Hans-Juergen Seyfarth, Eckhard Mayer, Michael Halank, Ekkehard Grünig

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension

    Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension Autor Ekkehard Grünig, Nicola Ehlken, Hossein Ardeschir Ghofrani, Gerd Staehler, F. Joachim Meyer, Jana Juenger, Christian Opitz, Hans Klose, Heinrike Wilkens, Stephan Rosenkranz, Horst Olschewski, Michael Halank

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Long-term outcome with intravenous iloprost in pulmonary arterial hypertension

    Long-term outcome with intravenous iloprost in pulmonary arterial hypertension Autor Marius M. Hoeper, Henning Gall, H.-J. Seyfarth, Michael Halank, Hossein Ardeschir Ghofrani, Jürgen Winkler, Heiko Golpon, Karen M. Olsson, Nils Nickel, Christian Opitz, Ralf Ewert

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension

    Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension Autor Christian Opitz, Roland Wensel, Jörg Winkler, Michael Halank, Leonhard Bruch, Franz‐Xaver Kleber, G. Höffken, Stefan D. Anker, Abdissa Negassa, Stephan B. Felix, Roland Hetzer, Ralf Ewert

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Assessment and Prognostic Relevance of Right Ventricular Contractile Reserve in Patients With Severe Pulmonary Hypertension

    Assessment and Prognostic Relevance of Right Ventricular Contractile Reserve in Patients With Severe Pulmonary Hypertension Autor Ekkehard Grünig, Henning Tiede, Esi Otuwa Enyimayew, Nicola Ehlken, Hans‐Jürgen Seyfarth, Eduardo Bossone, Antonello DʼAndrea, Robert Naeije, Horst Olschewski, Silvia Ulrich, Christian Nagel, Michael Halank, Christine Fischer

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension

    Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension Autor Marius M. Hoeper, Hanno Leuchte, Michael Halank, Heinrike Wilkens, F. Joachim Meyer, Hans-Juergen Seyfarth, Roland Wensel, F. Ripken, H. J. Bremer, Stefan Kluge, Gert Hoeffken, Jürgen Behr

    Vydáno 2006
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

    Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Autor Alberto M. Marra, Benjamin Egenlauf, Nicola Ehlken, Christine Fischer, Christina A. Eichstaedt, Christian Nagel, Eduardo Bossone, Antonio Cittadini, Michael Halank, Henning Gall, Karen M. Olsson, Tobias Lange, Ekkehard Grünig

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

    Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Autor Dominik Harzheim, Hans Klose, Fabiola Peña Pinado, Nicola Ehlken, Christian Nagel, Christine Fischer, Hossein Ardeschir Ghofrani, Stephan Rosenkranz, Hans‐Jürgen Seyfarth, Michael Halank, Eckhard Mayer, Ekkehard Grünig, Stefan Guth

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Exercise training in pulmonary arterial hypertension associated with connective tissue diseases

    Exercise training in pulmonary arterial hypertension associated with connective tissue diseases Autor Ekkehard Grünig, Felicitas Maier, Nicola Ehlken, Christine Fischer, Mona Lichtblau, Norbert Blank, Christoph Fiehn, Frank Stöckl, Felix Prange, Gerd Staehler, Frank Reichenberger, Henning Tiede, Michael Halank, Hans‐Jürgen Seyfarth, Simone Wagner, Christian Nagel

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Safety, tolerability and clinical effects of a rapid dose titration of subcutaneous treprostinil therapy in pulmonary arterial hypertension: a prospective multi-centre trial.

    Safety, tolerability and clinical effects of a rapid dose titration of subcutaneous treprostinil therapy in pulmonary arterial hypertension: a prospective multi-centre trial. Autor Benjamin Egenlauf, Ekkehard Grünig, Nicola Benjamin, TJ Lange, Ulrich Krüger, HF Klose, C Neurohr, Heinrike Wilkens, Michael Halank, HJ Seyfarth, Matthias Held, Andrew Traube, Michelle Pernow, RE Grover, Felix Gerhardt, Thomas Viethen, S. Rosenkranz

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Impairment of respiratory muscle function in pulmonary hypertension

    Impairment of respiratory muscle function in pulmonary hypertension Autor Hans‐Joachim Kabitz, Anja Schwoerer, Hinrich-Cordt Bremer, Florian Sonntag, Stephan Walterspacher, David Walker, Vanessa Schaefer, Nicola Ehlken, Gerd Staehler, Michael Halank, Hans Klose, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Ekkehard Gruenig, Wolfram Windisch

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018

    Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018 Autor Horst Olschewski, Jürgen Behr, Hinrich Bremer, Martin Claussen, Philipp Douschan, Michael Halank, Matthias Held, Marius M. Hoeper, S. J. Holt, Hans Klose, Stephan Krüger, Tobias Lange, Frank Reichenberger, Dirk Skowasch, Silvia Ulrich, Heinrike Wilkens, Werner Seeger

    Vydáno 2018
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  20. 20
    General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018

    General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018 Autor Ekkehard Grünig, Nicola Benjamin, Ulrich Krüger, Harald Kaemmerer, Satenik Harutyunova, Karen M. Olsson, Silvia Ulrich, Felix Gerhardt, C Neurohr, Armin Sablotzki, Michael Halank, Alberto M. Marra, Hans‐Joachim Kabitz, Günther Thimm, Klaus-Günther Fliegel, Hans Klose

    Vydáno 2018
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: